CA2499273A1 - Compositions a inhaler - Google Patents
Compositions a inhaler Download PDFInfo
- Publication number
- CA2499273A1 CA2499273A1 CA002499273A CA2499273A CA2499273A1 CA 2499273 A1 CA2499273 A1 CA 2499273A1 CA 002499273 A CA002499273 A CA 002499273A CA 2499273 A CA2499273 A CA 2499273A CA 2499273 A1 CA2499273 A1 CA 2499273A1
- Authority
- CA
- Canada
- Prior art keywords
- dry powder
- microns
- diameter
- less
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract 26
- 239000002245 particle Substances 0.000 claims abstract 17
- 239000000843 powder Substances 0.000 claims abstract 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract 12
- 239000008101 lactose Substances 0.000 claims abstract 12
- 239000003814 drug Substances 0.000 claims abstract 6
- 229940112141 dry powder inhaler Drugs 0.000 claims abstract 2
- OBRNDARFFFHCGE-PERKLWIXSA-N (S,S)-formoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-PERKLWIXSA-N 0.000 claims 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims 1
- 229960002848 formoterol Drugs 0.000 claims 1
- 229960000193 formoterol fumarate Drugs 0.000 claims 1
- 239000006185 dispersion Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention porte sur une composition à inhaler de poudre sèche contenant des particules de médicament et un mélange de particules de lactose avec diamètre volumétrique moyen compris entre environ 70 et 120 microns et un diamètre inférieur à 250 microns. Le mélange se caractérise par le fait que jusqu'à 96 % en poids des particules de lactose possèdent un diamètre inférieur à 150 microns, 25 % en poids des particules de lactose ont un diamètre inférieur à 5 microns. Ces compositions fournissent une dispersion plus précise, uniforme et régulière lorsqu'elles sont utilisées par exemple avec un inhalateur de poudre sèche. L'invention concerne aussi des procédés d'utilisation des compositions susmentionnées.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB02119513.9 | 2002-08-21 | ||
| GB0219513A GB0219513D0 (en) | 2002-08-21 | 2002-08-21 | Inhalation compositions including coarse carrier |
| GB02119513.7 | 2002-08-21 | ||
| PCT/US2003/026385 WO2004017914A2 (fr) | 2002-08-21 | 2003-08-21 | Compositions a inhaler |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2499273A1 true CA2499273A1 (fr) | 2004-03-04 |
| CA2499273C CA2499273C (fr) | 2011-06-21 |
Family
ID=9942746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2499273A Expired - Fee Related CA2499273C (fr) | 2002-08-21 | 2003-08-21 | Compositions a inhaler |
Country Status (8)
| Country | Link |
|---|---|
| BR (1) | BRPI0313647A2 (fr) |
| CA (1) | CA2499273C (fr) |
| ES (1) | ES2371601T3 (fr) |
| GB (1) | GB0219513D0 (fr) |
| NO (1) | NO20051461L (fr) |
| TN (1) | TNSN05047A1 (fr) |
| WO (1) | WO2004017914A2 (fr) |
| ZA (1) | ZA200502177B (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1744800B1 (fr) | 2004-04-21 | 2016-06-22 | Innovata Biomed Limited | Inhalateur |
| EP2708225B1 (fr) | 2004-04-23 | 2018-12-26 | CyDex Pharmaceuticals, Inc. | Formulation DPI contenant de la cyclodextrine d'éther de sulfoalkyle |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| EP3199164B1 (fr) | 2005-02-10 | 2020-03-18 | Glaxo Group Limited | Procedes de fabrication du lactose au moyen de techniques de pre-classification et preparations pharmaceutiques ainsi obtenues |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| GB0605723D0 (en) | 2006-03-23 | 2006-05-03 | 3M Innovative Properties Co | Powder filling processes |
| WO2008134817A1 (fr) * | 2007-05-03 | 2008-11-13 | The University Of Sydney | Vecteurs composites pour thérapie par inhalation de poudre sèche |
| TR201105367A2 (tr) * | 2011-06-02 | 2012-12-21 | Bi̇lgi̇ç Mahmut | Akış özellikleri geliştirilmiş bir kuru toz formülasyonu. |
| TR201205852A2 (tr) * | 2011-06-02 | 2012-12-21 | Bi̇lgi̇ç Mahmut | Geliştirilmiş yeni kuru toz formülasyonu. |
| US20150150802A1 (en) | 2012-07-05 | 2015-06-04 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhaler compositions comprising long acting muscarinic antagonists |
| WO2014014650A1 (fr) | 2012-07-19 | 2014-01-23 | 3M Innovative Properties Company | Appareil d'acheminement de poudre |
| JP6251667B2 (ja) | 2014-06-03 | 2017-12-20 | アサヒカルピスウェルネス株式会社 | 錠剤型即放性製剤及びその製造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1131059T3 (da) * | 1998-11-13 | 2003-06-30 | Jago Res Ag | Tørpulver til inhalation |
| ES2207867T3 (es) * | 1998-12-11 | 2004-06-01 | Pharmachemie B.V. | Preparacion farmaceutica para inhalacion de un opioide. |
| CA2395653C (fr) | 2000-10-12 | 2006-05-09 | Boehringer Ingelheim Pharma Kg | Nouvelle poudre a inhaler a teneur en tiotropium |
| UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
-
2002
- 2002-08-21 GB GB0219513A patent/GB0219513D0/en not_active Ceased
-
2003
- 2003-08-21 ES ES03751884T patent/ES2371601T3/es not_active Expired - Lifetime
- 2003-08-21 BR BRPI0313647A patent/BRPI0313647A2/pt active Search and Examination
- 2003-08-21 CA CA2499273A patent/CA2499273C/fr not_active Expired - Fee Related
- 2003-08-21 WO PCT/US2003/026385 patent/WO2004017914A2/fr not_active Ceased
-
2005
- 2005-02-18 TN TNP2005000047A patent/TNSN05047A1/en unknown
- 2005-03-15 ZA ZA200502177A patent/ZA200502177B/en unknown
- 2005-03-18 NO NO20051461A patent/NO20051461L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2499273C (fr) | 2011-06-21 |
| NO20051461L (no) | 2005-05-20 |
| ZA200502177B (en) | 2006-05-31 |
| WO2004017914A3 (fr) | 2004-04-29 |
| BRPI0313647A2 (pt) | 2019-02-19 |
| ES2371601T3 (es) | 2012-01-05 |
| WO2004017914A8 (fr) | 2005-07-07 |
| TNSN05047A1 (en) | 2007-05-14 |
| GB0219513D0 (en) | 2002-10-02 |
| WO2004017914A2 (fr) | 2004-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA29507C2 (uk) | Фармацевтична композиція для інгаляції та спосіб її одержання | |
| PL312210A1 (en) | Inhalable compositions | |
| CA2499273A1 (fr) | Compositions a inhaler | |
| WO2005079755A3 (fr) | Poudres antagonistes de l'interleukine-13, particules sechees par pulverisation, et procedes | |
| CA2409665A1 (fr) | Nouvelle composition | |
| CA2412561A1 (fr) | Distribution hautement efficace d'une grande quantite d'aerosol therapeutique | |
| CA2395653A1 (fr) | Nouvelle poudre a inhaler a teneur en tiotropium | |
| WO2002032410A3 (fr) | Administration de resveratrol pour traiter des pathologies respiratoires inflammatoires | |
| AU2001236207A1 (en) | Powder formulation | |
| CA2550841A1 (fr) | Nouvelle combinaison d'anticholinergique et de beta-mimetiques pour le traitement de maladies respiratoires | |
| AU2001293899A1 (en) | Ihnalation particles incorporating a combination of two or more active ingredients | |
| CA2409660A1 (fr) | Nouveau procede | |
| WO2021028679A8 (fr) | Composition pharmaceutique comprenant de l'ensifentrine | |
| WO2004012653A3 (fr) | Formulations de dehydroepiandrosterone a nebuliser et methodes de traitement de l'asthme ou de la bronchopneumopathie obstructive chronique a l'aide des compositions correspondantes | |
| EP1599209A4 (fr) | Compositions a inhaler | |
| DE60200202D1 (de) | Ein Chinolonderivat enthaltendes Arzneimittel und Verfahren zu dessen Herstellung | |
| RU2004103187A (ru) | Композиции инсулина для носового введения | |
| TNSN05048A1 (en) | Inhalation compositions with high drug ratios | |
| WO2002062317A3 (fr) | Medicaments | |
| TW200500066A (en) | New tiotropium containing powder formulation for inhalation | |
| WO2006030301A8 (fr) | Composition pharmaceutique contenant du cilostazol, a base de particules d'une taille inferieure a 50 micrometres |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20180821 |